Cas:258500-84-4 4-(3,4-dichlorophenyl)-1-methylpiperidine-4-carbonitrile manufacturer & supplier

We serve Chemical Name:4-(3,4-dichlorophenyl)-1-methylpiperidine-4-carbonitrile CAS:258500-84-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-(3,4-dichlorophenyl)-1-methylpiperidine-4-carbonitrile

Chemical Name:4-(3,4-dichlorophenyl)-1-methylpiperidine-4-carbonitrile
CAS.NO:258500-84-4
Synonyms:4-(3,4-dichlorophenyl)-1-methylpiperidine-4-carbonitrile
Molecular Formula:C13H14Cl2N2
Molecular Weight:269.17000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:27.03000
Exact Mass:268.05300
LogP:3.41828

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-(3,4-dichlorophenyl)-1-methylpiperidine-4-carbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(3,4-dichlorophenyl)-1-methylpiperidine-4-carbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(3,4-dichlorophenyl)-1-methylpiperidine-4-carbonitrile Use and application,4-(3,4-dichlorophenyl)-1-methylpiperidine-4-carbonitrile technical grade,usp/ep/jp grade.


Related News: With over 80 years of experience developing and manufacturing small molecules, UQUIFA has not only the knowledge and tools to successfully execute transfer activities but also the track record of success with several crucial drug commercialization,” Gurnurkar says. (S)-(-)-N-allyl-2,2-dibromo-1-methylcyclopropylmethylamine manufacturers Developed in collaboration with the sector, including academia, industry and charities with organizations such as Universities UK and GSK, 2-Phenyl-indolizine-8-carboxylic acid p-tolylamide suppliers The review considered two cases of AML in patients treated with an investigational medicine, bb1111, in a clinical trial for sickle cell disease. Although there have been no reports of AML with Zynteglo, both medicines use the same viral vector and there was a concern that the vector may be implicated in the development of the cancer (insertional oncogenesis). 1,3-dihydro-3,3-diphenyl-4-chloro-6-methyl-7-hydroxy-furo-(3,4-c)-pyridine vendor & factory.